Journal article
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
- Abstract:
-
rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa.We did an open-label, cluster-randomised ring vaccination trial (Ebola ça Suffit!) in the communities of Conakry and eight surrounding prefectures in the Basse-Guinée region of Guinea...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 842.5KB, Terms of use)
-
- Publisher copy:
- 10.1016/S0140-6736(16)32621-6
Authors
- Publisher:
- Elsevier
- Journal:
- Lancet More from this journal
- Volume:
- 389
- Issue:
- 10068
- Pages:
- 505-518
- Publication date:
- 2016-12-23
- Acceptance date:
- 2016-12-06
- DOI:
- EISSN:
-
1474-547X
- ISSN:
-
0140-6736
- Pmid:
-
28017403
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:997738
- UUID:
-
uuid:b00c99f2-40b3-4341-8232-dca3238c05ce
- Local pid:
-
pubs:997738
- Source identifiers:
-
997738
- Deposit date:
-
2019-05-29
Terms of use
- Copyright holder:
- Henao-Restrepo et al
- Copyright date:
- 2016
- Notes:
- © 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under a Creative Commons license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record